Clinical case of COVID-19 course in a child with aplastic anemia
https://doi.org/10.22625/2072-6732-2022-14-1-145-151
Abstract
The problem of the non-smooth course of COVID-19 and deaths in children with severe comorbid pathology is urgent. Among all registered cases of a new coronavirus infection in the Russian Federation, children account for up to 8,6%, of which severe forms are noted, as a rule, in patients with concomitant diseases. A clinical observation of the course of a new coronavirus infection in a child with a severe form of idiopathic aplastic anemia complicated by pancytopenia is presented. COVID-19 infection caused a sharp deterioration in the child’s condition. Despite the use of modern methods of therapy, there was a rapid deterioration of clinical and laboratory parameters: an increase in febrility, respiratory failure, interstitial changes in the lungs, a decrease in oxygen saturation to 70%, hemorrhagic, anemic syndromes and multiple organ failure with the development of a fatal outcome. Aplastic anemia is a factor predisposing to the severe course of COVID-19 and contributing to an unfavorable outcome.
About the Authors
D. O. Ivanov
Saint-Petersburg State Pediatric Medical University
Russian Federation
Competing Interests:
Russian Federation
Saint-Petersburg
Competing Interests:
Aвторы заявляют об отсутствии конфликта интересов.
Yu. V. Petrenko
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
R. A. Nasyrov
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
V. A. Reznik
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
V. N. Timchenko
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
T. A. Kaplina
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
S. L. Bannova
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
O. L. Krasnogorskaya
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
M. B. Paneyakh
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
E. P. Fedotova
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
G. V. Kondratyev
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
M. D. Subbotina
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
M. A. Shakmaeva
Saint-Petersburg State Pediatric Medical University
Russian Federation
Russian Federation
Saint-Petersburg
References
1. World Health Organization (WHO) Coronavirus disease (COVID-19) pandemic. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus2019(accessed12.12.2020).
2. Teslina A. Statistika CDC po smertyam detey s COVID-19. Medvestnik. Biblioteka vracha. Available at: https://medvestnik.ru/content/news/CDC-opublikovali-statistikupo-smertyam -detei-s-COVID-19.html (accessed 08.01.2021). (In Russ.)
3. Lu X., Zhang L., Du H. et al. SARS-CoV-2 infection in children. N Engl J. Med. 2020, 3: [e-pub]. DOI:.1056/NEJMc2005073.
4. Ivanov D.O., Petrenko Yu.V., Reznik V.A., Nasyrov R.A., Timchenko V.N., Subbotina M.D., Chernova T.M., Bannova S.L., Kondratiev G.V., Krasnogorskaya O.L., Paneyakh M.B., Fedotova E.P., Kaplina T.A., Shakmayeva M.A. Features of the course of a new coronavirus infection against the background of acute myeloblastic leukemia. Questions of practical pediatrics. 2021; 16(3): 121–129. DOI: 10.20953/1817-7646-2021-3-121-129.
5. Cao Q., Chen Y.C., Chen C.L., Chiu C.H. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. J. Formos Med Assoc. 2020; 3, 119 (3): 670–673. DOI: 10.1016/j.jfma.2020.02.009.
6. Chan J.F., Yuan S., Kok K.H. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395: 514–523.
7. Liu W., Zhang Q., Chen J. et al. Detection of COVID-19 in Children in Early January 2020 in Wuhan, China. N Engl J Med. 2020; 3: [Epub ahead of print]. Available at: https://www.nejm.org/doi/10.1056/NEJMc2003717. DOI: 10.1056/NEJMc2003717.
8. Gerashchenko Ya. L. A review of clinical guidelines for the management of patients with confirmed coronavirus disease (COVID-19) issued by the American National Center for Immunization and Respiratory Diseases (NCIRD). Available at: https://www.rmj.ru/articles/infektsionnye_bolezni/obzorklinicheskikh-rekomendatsiy-po-vedeniyu-patsientov-s-podtverzhdennoy-koronavirusnoy-boleznyu-covid-19-vypushimchennykh-amerisentny-respiratornykh-zabolevaniy-ncird/#ixzz6gPoajHip (in Russian)
9. Mazurov V.I., Gaidukova I.Z., Bakulin I.G., Inamova O.V., Fonturenko A.Yu., Samigullina R.R., Krylova A.I., Gaidukova E.K. Features of the course and factors of an unfavorable prognosis of coronavirus infection COVID-19 in patients with immuno-inflammatory diseases. RMZh. 2020; 9 (11): 4-8. Available at: https://www.rmj.ru/articles/infektsionnye_bolezni/Osobennosti_techeniya_i_faktory_neblagopriyatnogo_prognoza_koronavirusnoy_infekcii_COVID19_u_pacientov_s_immunzaboospalvans6SRglib (in Russian)
10. Mikhailova E.A., Parovichnikova E.N., Kulagin A.D., Troitskaya V.V., Voitsekhovsky V.V., Volodicheva E.M., Voronova E.V., Gaponova T.V., Klyasova G.A., Lapin V.A., Samoilova O.S., Fidarova Z.T., Savchenko V.G. Clinical practice guidelines for the treatment of aplastic anemia (combined immunosuppressive therapy). The recommendations of the IV Congress of Hematologists of Russia, 2018. (in Russian)
11. Zeng Y., Katsanis E. The complex pathophysiology of acquired aplastic anaemia. Clin. Exp. Immunol. 2015; 180, (3): 361–7.
12. Townsley D.M., Scheinberg P., Winkler T., Desmond R., Dumitriu B., Rios O., Weinstein B., Valdez J., Lotter J., Feng X., Desierto M., Leuva H., Bevans M., Wu C.O., Larochelle A., Calvo K.R., Dunbar C.E., Young N.S. Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med. 2017; 4, 376 (16): 1540–1550.
13. Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017; 129 (11): 1428-1436.
14. Ogawa S. Clonal hematopoiesis in acquired aplastic anemia. Blood. 2016; 128: 337-347.
15. Zinserling V.A., Vashukova M.A., Vasilyeva M.V., Isakov A.N., Lugovskaya N.A.,
16. Narkevich T.A., Sukhanova Yu.V., Semenova N.Yu., Gusev D.A. Issues of pathology of a new coronavirus infection CoVID-19. Journal Infectology. 2020;12(2):5-11. (In Russ.) https://doi.org/10.22625/2072-6732-2020-12-2-5-11
Review
For citations:
Ivanov D.O., Petrenko Yu.V., Nasyrov R.A., Reznik V.A., Timchenko V.N., Kaplina T.A., Bannova S.L., Krasnogorskaya O.L., Paneyakh M.B., Fedotova E.P., Kondratyev G.V., Subbotina M.D., Shakmaeva M.A. Clinical case of COVID-19 course in a child with aplastic anemia. Journal Infectology. 2022;14(1):145-151. (In Russ.) https://doi.org/10.22625/2072-6732-2022-14-1-145-151
Views:
561
.png)
.png)
Email this article 